Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression
about
Cell-mediated immunity to human CMV infection: a brief overviewActivation of Virus-specific Memory B Cells in the Absence of T Cell HelpNovel microneutralization assay for HCMV using automated data collection and analysis.Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeCytomegalovirus vaccine developmentExperimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Progress toward an elusive goal: current status of cytomegalovirus vaccines.Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.Synthetic DNA approach to cytomegalovirus vaccine/immune therapyAdenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.Vaccine strategies against human cytomegalovirus infection.Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.Cytomegalovirus Vaccines: Current Status and Future Prospects.Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.Subviral dense bodies of human cytomegalovirus stimulate maturation and activation of monocyte-derived immature dendritic cells.The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles.Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65.Protein delivery by subviral particles of human cytomegalovirus.Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
P2860
Q27026981-55980DE3-E85A-485E-A6A9-8C1C60635E2FQ27485181-E3F53B30-2D65-4D47-88A2-45F416BC2876Q31104639-4276AD67-872C-4EDC-A623-8BBB62EFB5BFQ33551402-98B2DF32-DF1E-42DB-A82C-34AF08D891F7Q33702990-47CDF195-E33A-452B-8981-E9716BD3AA89Q33843590-C153CAE9-55EB-4E79-8A74-9E7A7258F6DEQ34102747-1C11F94F-D546-417F-83BA-3FAE25A6109FQ34349745-9C09FD24-5F89-4EDB-8216-BE0DB6F28FDDQ34434818-F50E159D-6E2D-4DA8-A9E5-984909835648Q34782568-98F9CDF4-334C-4254-9804-F3D5DC550B6BQ35917480-338F8E44-49E5-4C21-A96A-B7EA8D3FEBC0Q36069582-B3BB6657-7B2F-4E14-A3A5-551196239A74Q36645514-9B40FD0B-2E2F-425A-84A1-514FBA6898D9Q36757818-0A8ECB49-4D87-4E27-A1A3-7125A026DD29Q36839736-8061BF77-1F24-41D0-9401-2CA931BDCE00Q37252609-6355ED4A-FB29-48B4-AF46-41FDAEE3B559Q37406553-C5834894-4CED-4D6B-B210-EF7A0163CE10Q37409233-15D25628-B0BD-47AD-AEF7-9F490BE2AE27Q37559627-81E8B69F-A969-4462-A22B-FDABEE72D0E8Q37574334-8037E95A-0FC0-4B18-B180-65BF2656A3E9Q38703173-3F698FCE-5FC7-4420-BE06-D37BE20E7541Q38791353-FFA7D42C-4E09-44DC-8683-33ED1291F681Q39960613-1EC6CC7A-A3FA-40A0-9514-C48C93F452BDQ40163004-D49AAF7C-4E70-4ED1-B95B-334D85C7CC51Q40169615-F6C67E8A-485D-4654-BE7A-C15AA88B45E7Q41991559-1604F53F-A2CA-4EAC-9BC0-327F8EF45C1BQ42126964-9639E0E9-F91D-4691-B3C7-4B75F76A78FFQ44245356-95AF580C-3BE5-463A-9FF3-105A4A5A8D95Q45858395-53623B1F-B63A-4AF4-AB24-6F09C64634D6Q47115255-BEBBF2EF-BAE7-4035-A5DD-527E01B73D78Q47605886-14DE268C-3285-47A0-9C76-BDF558A0D2DB
P2860
Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dense bodies of human cytomega ...... sence of viral gene expression
@ast
Dense bodies of human cytomega ...... sence of viral gene expression
@en
type
label
Dense bodies of human cytomega ...... sence of viral gene expression
@ast
Dense bodies of human cytomega ...... sence of viral gene expression
@en
prefLabel
Dense bodies of human cytomega ...... sence of viral gene expression
@ast
Dense bodies of human cytomega ...... sence of viral gene expression
@en
P2093
P2860
P1433
P1476
Dense bodies of human cytomega ...... sence of viral gene expression
@en
P2093
P2860
P304
P356
10.1128/JVI.74.13.6132-6146.2000
P577
2000-07-01T00:00:00Z